CREB1 and cancer: This interesting finding gives strong support that miR-301a and Cip2a are integral part of a regulatory loop in which increasingly high levels of Cip2a promotes cancer progression by up-regulation of miR-301a, whereas high miR-301a expression activates ERK/CREB signaling, which in turn increases the expression of Cip2a.